Snail Shares Soar 174% After Q1 Revenue Jumps And Returns To Profit

India, May 14 -- Snail, Inc. (SNAL) shares skyrocketed 173.85 percent to $1.3750, up $0.8729 on Thursday, after the video game publisher reported sharply higher first-quarter revenue and a return to p... Read More

Penang exco denies claim 365 foreign-owned units sold below ceiling price, says figures misinterpreted

Kuala Lampur, May 14 -- GEORGE TOWN, May 14 - The Penang state government has denied allegations that 365 units of properties in the state were sold under the set ceiling price for foreigners, as alle... Read More

Indian Shares Likely To Drift Lower As Gulf Tensions Flare Up

India, May 14 -- Indian shares are seen opening lower on Friday following mixed cues from global markets. Geopolitical tensions returned to the fore as efforts to resolve the Iran war face a stalemate... Read More

Reshmi, the child shot by criminals in Chattogram, has died of her wounds

Dhaka, May 14 -- The 11-year-old girl who was shot in the eye in the Raufabad area of Chattogram's Bayezid Bostami Thana has succumbed to her wounds. Reshmi Akter passed away around 9:45am on Thursda... Read More

Odisha Vigilance raids Bhadrak CAD Engineer's properties over DA allegations, search underway

Bhubaneswar, May 14 -- OdishaVigilance on Thursday launched simultaneous searches at properties linked to Bhadrak CAD Division Junior Engineer Bijay Kumar Mohanty over allegations of possession of ass... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Efficacy of Efimosfermin Alfa in Participants With Biopsy-Confirmed F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-1)

Singapore, May 14 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Tolerability of Efimosfermin Alfa in Participants With Known or Suspected F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-2)

Singapore, May 14 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More

Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, May 14 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combine... Read More

Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, May 14 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combine... Read More

Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, May 14 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the pos... Read More

• ««
• «
• 19010
• 19011
• 19012
• 19013
• 19014
• 19015
• 19016
• 19017
• 19018
• 19019
• »
• »»